6 completed. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 1 | Completed 1 |
Follow Exercise-Induced Allergies: new trials by email Literature Review of Exercise-Induced Allergies trials Research Report on Exercise-Induced Allergies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients budesonide, terbutaline, budesonide/formoterol - Exercise Induced Asthma | Phase 2 | Completed | AstraZeneca | 66 | 2009-09-01 | 2012-08-14 |
| Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma senicapoc, Placebo - Exercise Induced Asthma | Phase 2 | Completed | Icagen | 69 | 2009-03-01 | 2011-07-14 |
| A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise Placebo, GSK2190915 - Asthma | Phase 2 | Completed | GlaxoSmithKline | 47 | 2008-12-01 | 2017-09-19 |
| To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol Combination DSCG and Reproterol - Asthma, Exercise-Induced | Phase 2 | Completed | MEDA Pharma GmbH & Co. KG | 62 | 2007-11-01 | 2022-02-07 |
| Study of Oglemilast for the Prevention of Asthma. Oglemilast, Placebo - Exercise-Induced Asthma | Phase 2 | Completed | Forest Laboratories | 24 | 2006-05-01 | 2012-04-10 |
| Safety Study of Zileuton Injection in Patients With Asthma Zileuton injection - Asthma | Phase 1 / Phase 2 | Completed | Critical Therapeutics | 60 | 2006-01-01 | 2007-09-26 |
Asthma, Exercise-Induced (6) · Asthma (3) · Bronchial Spasm (1) · Inflammation (1) · Motor Activity (1)
Bronchial Diseases (6) · Hypersensitivity (6) · Hypersensitivity, Immediate (6) · Immune System Diseases (6) · Respiratory Hypersensitivity (6) · Respiratory Tract Diseases (6) · Asthma (3) · Lung Diseases (3) · Lung Diseases, Obstructive (3) · Behavior (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
3-(3-tert-butylsulfanyl-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropionic acid (1) · Budesonide (1) · Budesonide, Formoterol Fumarate Drug Combination (1) · Terbutaline (1) · oglemilast (1) · reproterol (1) · senicapoc (1) · zileuton (1)
AstraZeneca (1) · Critical Therapeutics (1) · Forest Laboratories (1) · GlaxoSmithKline (1) · Icagen (1) · MEDA Pharma GmbH & Co. KG (1)
United States (4) · Germany (1) · Norway (1) · Sweden (1)
Dana Hilt, MD (1) · Georgios Stratelis (1) · Jonathon Stocker, Ph.D. (1) · Kjell Larsson, Professor (1) · Roland Buhl, MD, Prof. (1)